Clearmind Medicine Inc. Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement
Clearmind Medicine Inc. (CMND) had Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement of 349025600.00% as of 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement · last filed 2026-03-12
- 2026-01-31: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 349025600.00%.
- 2025-10-31: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 388155100.00%.
- 2025-07-31: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 388155100.00%.
- 2025-04-30: Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement 388155100.00%.
| Period end | Number Of Other Equity Instruments Outstanding In Share-based Payment Arrangement |
|---|---|
| 2026-01-31 | 349025600.00% 6-K · filed 2026-03-12 |
| 2025-10-31 | 388155100.00% 6-K · filed 2026-03-12 |
| 2025-07-31 | 388155100.00% 6-K · filed 2025-09-11 |
| 2025-04-30 | 388155100.00% 6-K · filed 2025-06-12 |
| 2025-01-31 | 388155100.00% 6-K · filed 2025-03-13 |
| 2024-10-31 | 442954700.00% 6-K · filed 2026-03-12 |
| 2024-07-31 | 457417700.00% 6-K · filed 2024-09-16 |
| 2023-10-31 | 1123146500.00% 20-F · filed 2026-01-20 |
| 2023-10-30 | 1123146500.00% 6-K · filed 2024-09-16 |
| 2022-10-31 | 1976300.00% 20-F · filed 2025-01-22 |
| 2022-10-30 | 1976300.00% 6-K · filed 2024-09-16 |